Skip to main content
. 2021 May 4;16:40. doi: 10.1186/s13011-021-00377-8

Table 3.

Average scale scores

(n = 52)
Items mean ± SD (Range)
Bidimensional Resilience Scale
 Innate resilience 35.3 ± 7.3 (23–58)
 Acquired resilience 29.4 ± 4.7 (20–41)
Stimulant Relapse Risk Scale
 Anxiety and intention to use drugs 14.5 ± 4.0 (8–23)
 Emotionality problem 16.5 ± 4.2 (8–24)
 Compulsivity for drugs 5.5 ± 2.1 (4–12)
 Positive expectancies and lack of control over drugs 13.0 ± 3.6 (6–8)
 Lack of negative expectancy for the drug 5.7 ± 1.9 (4–10)
 Awareness of illness 11.9 ± 2.3 (6–15)
 Total 67.1 ± 16.5 (43–93)

n number of participants